Vigilare Wealth Management Pfizer Inc Transaction History

Vigilare Wealth Management

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 11, 2023	SELL	$36.12 - $41.79 $334,832 - $387,393	-9,270 Reduced 59.48%	6,314 $231,000
Q1 2023 Apr 17, 2023	SELL	$39.39 - $51.28 $320,477 - $417,214	-8,136 Reduced 34.3%	15,584 $635,000
Q4 2022 Jan 10, 2023	SELL	$41.75 - $54.5 $4,049 - $5,286	-97 Reduced 0.41%	23,720 $0
Q3 2022 Oct 20, 2022	SELL	$43.76 - $53.42 $61,745 - $75,375	-1,411 Reduced 5.59%	23,817 $1.04 Million
Q2 2022 Jul 11, 2022	SELL	$46.53 - $55.17 $308,633 - $365,942	-6,633 Reduced 20.82%	25,228 $1.32 Million
Q1 2022 Apr 06, 2022	BUY	$45.75 - $56.69 $135,099 - $167,405	2,953 Added 10.22%	31,861 $1.65 Million
Q4 2021 Jan 07, 2022	BUY	$41.32 - $61.25 $329,444 - $488,346	7,973 Added 38.08%	28,908 $1.71 Million
Q3 2021 Oct 19, 2021	BUY	$39.25 - $50.42 $80,266 - $103,108	2,045 Added 10.83%	20,935 $900,000
Q2 2021 Jul 16, 2021	BUY	$35.91 - $40.68 $238,155 - $269,789	6,632 Added 54.1%	18,890 $740,000
Q1 2021 Apr 29, 2021	SELL	$33.49 - $37.77 $125,754 - $141,826	-3,755 Reduced 23.45%	12,258 $444,000
Q4 2020 Jan 14, 2021	SELL	$33.47 - $42.56 $83,474 - $106,144	-2,494 Reduced 13.48%	16,013 $589,000
Q3 2020 Oct 15, 2020	BUY	$31.75 - $37.25 $190 - $223	6 Added 0.03%	18,507 $679,000
Q2 2020 Jul 20, 2020	SELL	$30.12 - $36.54 $1,475 - $1,790	-49 Reduced 0.26%	18,501 $605,000
Q1 2020 May 04, 2020	SELL	$27.03 - $38.62 $76,873 - $109,835	-2,844 Reduced 13.29%	18,550 $605,000
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $704,290 - $799,279	21,394 New	21,394 $802,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Vigilare Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Vigilare Wealth Management with notifications on news.